Kenneth Shock

Kenneth Shock is an ALS patient in the United States who serves as the second participant in Neuralink's VOICE clinical trial, which investigates brain-computer interfaces for restoring speech in individuals with severe speech impairment. He received his Neuralink implant in January 2026, enabling him to communicate through an AI-generated version of his own voice by decoding imagined speech without physical vocalization. The technology allows him to operate a computer, edit videos, and interact with digital tools independently, restoring a degree of autonomy that ALS had progressively taken from him.